Colony Group LLC Bausch Health Companies Inc. Transaction History

Colony Group LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	SELL	$7.06 - $23.63 $4,144 - $13,870	-587 Reduced 0.38%	154,531 $1.29 Million
Q1 2022 May 16, 2022	BUY	$21.6 - $27.79 $7,776 - $10,004	360 Added 0.23%	155,118 $3.54 Million
Q4 2021 Feb 15, 2022	SELL	$23.0 - $29.01 $258,681 - $326,275	-11,247 Reduced 6.78%	154,758 $4.27 Million
Q3 2021 Nov 17, 2021	BUY	$25.04 - $30.06 $8,012 - $9,619	320 Added 0.19%	166,005 $4.62 Million
Q2 2021 Aug 18, 2021	SELL	$27.43 - $32.7 $45,369 - $54,085	-1,654 Reduced 0.99%	165,685 $4.86 Million
Q1 2021 May 21, 2021	BUY	$21.37 - $34.38 $625,670 - $1.01 Million	29,278 Added 21.21%	167,339 $5.31 Million
Q4 2020 Feb 16, 2021	SELL	$15.31 - $21.12 $327,634 - $451,968	-21,400 Reduced 13.42%	138,061 $2.87 Million
Q3 2020 Nov 17, 2020	BUY	$14.88 - $20.13 $1.04 Million - $1.41 Million	70,058 Added 78.36%	159,461 $2.48 Million
Q2 2020 Aug 13, 2020	BUY	$13.31 - $20.51 $105,947 - $163,259	7,960 Added 9.77%	89,403 $1.64 Million
Q1 2020 May 18, 2020	BUY	$12.98 - $30.25 $1.06 Million - $2.46 Million	81,443 New	81,443 $1.26 Million

252

254M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.63B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Colony Group LLC, based on Form 13F filings with the SEC.

Stay updated on Colony Group LLC with notifications on news.